Oral Cancer: Page 23

ASTRO: HPV+ patients don't need high treatment doses
By Donna Domino
Less intense treatment of low-risk HPV-related oropharyngeal cancer can achieve good patient outcomes with less toxicity, according to a presentation at the recent American Society for Radiation Oncology (ASTRO) annual meeting.
October 27, 2015
2013 09 03 14 41 25 490 Hpv 200
ASTRO: New ultrasound gene therapy may treat xerostomia
By Donna Domino
Gene therapy using an innovative ultrasound procedure to transfer therapeutic DNA into cells is being developed to treat xerostomia, according to a presentation at the 2015 American Society for Radiation Oncology (ASTRO) conference.
October 21, 2015
2013 06 20 16 42 16 777 Sound Wave 200
Study: TORS produces good outcomes for HNC patients
By Donna Domino
Transoral robotic surgery (TORS) has produced favorable outcomes for the treatment of head and neck cancer (HNC), especially for patients with oropharyngeal cancer, according to a large, international, multicenter study.
October 18, 2015
2015 04 20 15 39 28 178 Cancer Cell Target 200
Galera raises $37M to develop treatment for mucositis
By DrBicuspid.com staff writers
Biotech company Galera Therapeutics has raised $37 million in funding to support the development of a treatment to prevent oral mucositis in head and neck cancer patients receiving chemoradiation therapy.
October 15, 2015
Biotech start-up gets $1.5M to develop HNC treatment
By DrBicuspid.com staff writers
Biotech start-up SuviCa has been awarded about $1.5 million from the National Cancer Institute to develop novel treatments for head and neck cancer (HNC).
October 15, 2015
Dara Biosciences launches tablet to treat oral thrush
By DrBicuspid.com staff writers
Pharmaceutical company Dara BioSciences has launched its Oravig tablet to treat oral thrush for the U.S. oncology and primary care markets.
October 5, 2015
Vigilant appoints new VP of commercialization
By DrBicuspid.com staff writers
Vigilant Biosciences has announced the appointment of James McMenamy as vice president of commercialization.
October 4, 2015
UNC researcher, biotech firm partner on rapid oral HPV test
By DrBicuspid.com staff writers
A University of North Carolina (UNC) researcher and a California-based biotechnology company are partnering to create a rapid oral test for HPV.
October 1, 2015
UbiVac, J &J to develop oral cancer vaccine
By DrBicuspid.com staff writers
Biotechnology company UbiVac will collaborate with Johnson & Johnson (J&J) Innovation to develop and test an oral cancer vaccine.
September 29, 2015
Can a laser detect oral cancer?
By Donna Domino
Lasers may soon be used to detect oral cancer, replacing invasive biopsies, according to a University of California researcher who has developed a low-cost, simple device using optical coherence tomography to analyze oral lesions.
September 23, 2015
2014 06 19 10 46 55 930 Laser Red Beams 200
HPV vaccine could eliminate recurrent oral papillomas
By Donna Domino
The HPV vaccine could eliminate recurrent oral squamous cell papillomas, according to a new case report in JAMA Dermatology. An immunocompetent patient with chronic oral warts was cleared of all lesions three months after receiving the quadrivalent HPV vaccine.
September 22, 2015
2014 08 25 16 33 23 1 Hpv Virus Nih 200
Salivary Test for Oral Cancer Now Available
Oral squamous cell carcinoma (OSCC) is the sixth leading cancer worldwide and the fourth in African-American men. The mortality of this disease has not significantly improved in decades and this is largely due to late diagnosis. A new salivary test can help improve these statistics.
September 22, 2015
2015 09 23 07 04 57 32 200x200 Perirx
Previous Page
Page 23 of 117
Next Page